Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Silence Therapeutics Plc ADR
(NQ:
SLN
)
16.20
+0.67 (+4.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silence Therapeutics Plc ADR
< Previous
1
2
3
4
Next >
74 Biggest Movers From Yesterday
April 29, 2022
Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 28, 2022
Via
Benzinga
Silence Therapeutics Posts First Human Data For Cardiovascular Candidate
February 09, 2022
Silence Therapeutics plc (NASDAQ: SLN) showed that its RNAi technology could
Via
Benzinga
61 Biggest Movers From Yesterday
April 28, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
April 27, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...
Via
Benzinga
Silence Therapeutics Achieves $2 Million Research Milestone in Hansoh Pharma Collaboration
April 25, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces Publication in the Journal of the American Medical Association Highlighting Results From SLN360 Phase 1 Study in Healthy Adults With High Lipoprotein(a)
April 03, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces Detailed Results From SLN360 Phase 1 Study in High Lipoprotein(a) Presented in Late Breaker at the American College of Cardiology (ACC.22) Annual Meeting
April 03, 2022
From
Silence Therapeutics plc
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
March 31, 2022
Upgrades
Via
Benzinga
Silence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501
March 23, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Reports Fourth Quarter and Full Year 2021 Results
March 17, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Appoints Craig Tooman President and Chief Executive Officer
February 21, 2022
From
Silence Therapeutics plc
Via
Business Wire
Earnings Scheduled For March 17, 2022
March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...
Via
Benzinga
Silence Therapeutics Announces Positive Topline Data in SLN360 Phase 1 Single-Ascending Dose Study in Healthy Adults with High Lipoprotein(a)
February 09, 2022
From
Silence Therapeutics plc
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
February 22, 2022
During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...
Via
Benzinga
Silence Therapeutics Announces SLN360 Phase 1 Data Accepted for Late-Breaking Presentation at the American College of Cardiology (ACC) Annual Scientific Session and Expo
January 26, 2022
From
Silence Therapeutics plc
Via
Business Wire
51 Biggest Movers From Yesterday
January 26, 2022
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients...
Via
Benzinga
Silence Therapeutics’ Head of Molecular Design Dr. Marie Wikström Lindholm Appointed to Oligonucleotide Therapeutics Society Board of Directors
January 18, 2022
From
Silence Therapeutics plc
Via
Business Wire
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
October 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For...
Via
Benzinga
Exposures
COVID-19
Product Safety
Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript
August 12, 2021
SLN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Silence Therapeutics' siRNA Candidate Reduces Plasma Iron Levels, Early-Stage Study Shows
May 19, 2021
Silence Therapeutics plc (NASDAQ: SLN) has announced topline data from GEMINI Phase 1 study evaluating SLN124 for iron-loading anemia conditions, thalassemia, and...
Via
Benzinga
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics
May 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Silence Therapeutics Plc (SLN) Q4 2020 Earnings Call Transcript
May 03, 2021
SLN earnings call for the period ending December 31, 2020.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
April 29, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) stock rose 21.78% to $8.05 during Thursday's regular session. As of 12:32 EST, Galera Therapeutics's stock is trading at...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.